Categories
1 Minute-Read

Ravelcare shares jump 55% on debut

Ravelcare made a strong market debut on December 8, 2025, listing at ₹201 per share on the BSE SME platform, up nearly 55% from its IPO price of ₹130.

The IPO, aimed at raising ₹24.1 crore through 18.54 lakh fresh shares, saw overwhelming demand, being subscribed around 406 times. The funds will support marketing, advertising, and a new manufacturing facility in Amravati, along with general corporate purposes.

Early grey‑market trading had indicated a strong premium, and the listing confirmed investors’ enthusiasm for the company’s beauty and personal‑care business.

Categories
1 Minute-Read

Corona Remedies IPO shines, 33% subscribed on Day 1

Corona Remedies launched its ₹655 crore IPO on December 8 with a price band of ₹1,008–1,062 per share.

On the first day, the issue saw 33% subscription, with 14.75 lakh shares bid against 45.71 lakh shares on offer. The grey-market is trading at a premium of around ₹290, indicating positive investor sentiment.

The company reported FY25 revenue of ₹1,196 crore, EBITDA of ₹246 crore, and a profit after tax of ₹149.43 crore, reflecting strong financials.

The subscription window closes December 10, with listing expected on BSE/NSE around December 15, making it a closely watched IPO.

Categories
1 Minute-Read

Air India follows Government directive, caps ticket prices

Air India has introduced fare caps on domestic flights following a government directive after IndiGo canceled hundreds of flights, leaving travelers stranded.

Economy-class fares are now limited to ₹7,500 for flights under 500 km, ₹12,000 for 500–1,000 km, ₹15,000 for 1,000–1,500 km, and ₹18,000 for flights over 1,500 km, excluding taxes.

Air India and Air India Express started applying caps from December 4, and passengers who booked above the limits will receive refunds.

The move aims to protect travelers and ensure price stability amid the ongoing aviation disruption.

Categories
1 Minute-Read

Purple Wave Infocom ₹31.45 cr IPO opens modestly

Purple Wave Infocom made its BSE‑SME debut today after raising ₹31.45 crore through a fresh issue of nearly 25 lakh shares.

The company, specializing in professional audio-video (PRO AV) and smart display solutions, saw its IPO subscribed about 6.9 times, reflecting strong investor interest, particularly from institutions.

However, the grey-market premium (GMP) was at zero ahead of listing, suggesting the stock may open close to its IPO price.

Analysts expect only modest gains for Purple Wave Infocom, on the first trading day, despite healthy revenue and profit growth in the previous year. Investors are watching the debut closely.

Categories
1 Minute-Read

Logiciel Solutions ₹40 cr IPO debuts with flat sentiment

Logiciel Solutions is set to debut on the BSE SME platform today, following the closure of its ₹40 crore IPO on December 2.

The issue included a ₹32.7 crore fresh offer and ₹7.2 crore offer-for-sale, priced between ₹183–₹193 per share.

Overall subscription stood at a modest 2.04×, with retail investors driving most of the demand.

Pre-listing grey market activity indicates a zero premium, reflecting cautious investor sentiment and expectations of a flat listing.

Market watchers will closely track the debut, as the company ventures into the public domain amid subdued investor interest.

Categories
1 Minute-Read

NephroPlus files IPO, plans Dec. 10 launch

Nephrocare Health Services, operating as NephroPlus, has filed its Red Herring Prospectus to launch an initial public offering (IPO) on December 10.

The IPO will comprise a fresh issue of shares worth ₹353.4 crore along with an offer-for-sale of up to 1.12 crore shares by existing investors.

The company plans to use around ₹129.1 crore to set up new dialysis centres, ₹136 crore to repay debt, and the remainder for general corporate purposes.

With 519 clinics across India, NephroPlus is Asia’s largest dialysis service provider, aiming to strengthen its presence nationwide.

Categories
1 Minute-Read

H-1B applicants face expanded US social media scrutiny

The United States has announced stricter vetting for all H-1B and H-4 visa applicants from December 15.

Under the new rules, applicants must keep their social-media profiles public. Consular officers will review online activity, work history, and any involvement in content moderation, misinformation tracking, or roles that may be seen as restricting protected speech.

Anyone found to have “censored or attempted to censor” expression in the US could be denied a visa. The changes are expected to affect many Indian tech workers, especially those in digital safety or moderation roles, and may lead to delays or higher rejections.

Categories
1 Minute-Read

Corona Remedies IPO opens Dec 8 at ₹1,008–1,062

Corona Remedies will open its ₹655.37-crore initial public offering on 8 December, closing on 10 December.

The IPO is entirely an Offer for Sale, with promoters and existing investors selling 61.7 lakh shares. The price band has been set at ₹1,008–₹1,062 per share.

Retail investors can bid for a minimum lot of 14 shares, costing around ₹14,868 at the upper band.

Quotas are split as 50% for institutional buyers, 35% for retail, and 15% for NIIs. As no fresh shares are being issued, the company will not receive new capital from the offer.

Categories
1 Minute-Read

PMO’s new address named “Seva Teerth”

The new Prime Minister’s Office (PMO) complex in New Delhi has been officially named Seva Teerth, meaning “service pilgrimage,” under the Central Vista Redevelopment Project.

The complex will house the PMO, Cabinet Secretariat, National Security Council, and “India House” for high-level meetings.

Officials say the name highlights service over authority, signalling that governance is about citizens’ welfare.

This follows renaming trends like the PM’s residence to Lok Kalyan Marg and the Secretariat to Kartavya Bhavan, reflecting India’s ethos of duty, responsibility, and public service.

Categories
1 Minute-Read

Ravelcare IPO subscribed six times on strong debut

Ravelcare’s IPO opened on December 1 with a plan to raise ₹24.10 crore through a fresh issue.

The price band is fixed at ₹123–₹130 per share, and the minimum retail application requires two lots, totalling 2,000 shares.

On Day 1, the IPO saw strong interest, getting subscribed around six to seven times, driven mainly by retail and SME investors.

The grey-market premium hovered near ₹52, indicating expectations of healthy listing gains.

The public issue closes on December 3, with allotment likely on December 4. Shares are scheduled to list on the BSE SME platform on December 8.